Treatment of ALK+ ALCL cell lines with the mTOR inhibitor, rapamycin, resulted in reduced proliferation [123, 125–127, 129] and the induction of apoptosis [126, 127]. Here, ALK is linked to anaplastic large cell lymphoma.